The largest database of trusted experimental protocols

20 protocols using sanger sequenced

1

Validating Genome Edits by PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the presence of exogenous sequences inserted by homology-directed-repair, or the presence of insertions and deletions, PCR amplicons surrounding the putative cut site were generated from genomic DNA (see Table S2 for primer sequences). Purified amplicons were Sanger sequenced (Genewiz), or used as a template for a restriction digest using BamHI (R0136, New England Biolabs [NEB]) or PacI (R0547, NEB).
+ Open protocol
+ Expand
2

Knock-in of donor plasmids in sheep oocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
KI of donor plasmids was attempted using laser-assisted cytoplasmic injection20 (link) of in vitro matured oocytes after 18 h of maturation and in vitro fertilized embryos 6 hpi with 6 pL of a solution containing 67 ng/μL of in vitro transcribed gRNA, 167 ng/μL of Cas9 protein (PNA Bio) and 133 ng/μL of donor plasmid. Injected MII oocytes were subsequently co-cultured with cumulus-oocyte-complexes (COCs) and in vitro fertilized following procedures previously described for sheep26 (link). Embryos were scored for developmental stage reached at day 7–8. Embryos that reached blastocyst stage were lysed as described above and underwent whole-genome amplification using the Repli-G Mini kit (Qiagen). Target regions were amplified using primers developed using Primer3 (Supplementary Information, Fig. S1 and Table S4)39 (link),40 (link). PCR was performed on a thermal cycler with 12.5 μL LongAmp Taq 2X Master Mix (NEB), 9.5 μL of H2O, 1 μL of each primer at 10 mM and 1 μL of DNA for 5 min at 94 °C, 35 cycles of 30 s at 94 °C, 30 s at anneal temp (Supplementary Information, Table S4) and 4 min at 65 °C, followed by 15 min at 65 °C. Products were visualized on a 1% agarose gel using a gel imager, purified using the QIAquick Gel Extraction Kit (Qiagen) and Sanger sequenced (GeneWiz).
+ Open protocol
+ Expand
3

CHIKV Genome Sequencing from Mosquito Saliva

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mosquito saliva was collected as described above (Mosquito infection—force salivation). The DMEM plus saliva mixture was mixed with TRIzolTM reagent, RNA extracted, and cDNA synthesized as described above (filter paper assay). We amplified the structural region of the CHIKV genome using two overlapping PCR products (Fragment 1 and Fragment 2—primer sequences found in Table S1, Supplementary Materials). Resulting PCR products of the correct size were purified using a PCR cleanup kit (Macherey–Nagel, Bethlehem, PA, USA) and Sanger sequenced (Genewiz, South Plainfield, NJ, USA) (sequencing primer sequences can be found in Table S1, Supplementary Materials).
+ Open protocol
+ Expand
4

Mosquito Salivary Gland Transcriptome Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mosquito salivary glands were extracted from individual mosquitos and placed in TRIzolTM reagent. RNA was extracted and used for cDNA synthesis as described above. The D7 long form transcript was amplified by PCR and Sanger sequenced (Genewiz) using the same primers (primer sequences can be found in Table S1 in the Supplementary Materials).
+ Open protocol
+ Expand
5

Sequencing Ciprofloxacin-Resistant Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
As indicated before, samples of resistant colonies were isolated from the selective plates of the SE and grown overnight in LB + 2 μg/ml cipro to create frozen stocks. A sample from these overnight cultures was used to amplify the spoT (in some cases, also gyrA) through PCR, and then the amplification products were Sanger sequenced (GENEWIZ) and analyzed for mutations using CLC Genomics Workbench 20.
The whole-genome sequencing results obtained for the ciproR mutants characterized in this study were confirmed with Sanger sequencing (GENEWIZ).
A list of all the primers used for Sanger sequencing is included in the Supplementary Table S2.
+ Open protocol
+ Expand
6

Py Circumsporozoite Protein DNA Vaccine with Adjuvant

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Py circumsporozoite protein (CSP) DNA vaccine plasmids were constructed in the pUb.3 vector and co-administered with Escherichia coli heat-labile toxin (LT)-encoding plasmid adjuvant as described [19 (link), 36 (link)-38 (link)]. The PyCSP-minigene encodes the SYVPSAEQI epitope and the PyCSP plasmid encodes the full-length CSP protein without the major repeat region. Supplementary Fig. 1 details amino acid sequences and agarose gel restriction digest plasmid validation for all PyCSP vaccines. All plasmid stocks were Sanger sequenced (GeneWiz Inc.) before use. Gene gun DNA vaccine cartridges were constructed as previously described [20 (link), 37 (link)]. Mice were vaccinated on a shaved abdomen using a PowderJect-style gene gun by priming using two cartridges per day on Days 0 and 2 (0.5 μg DNA per cartridge). This method of priming with PyCSP/LT-encoding plasmids via gene gun is referred to as ggCSP.
+ Open protocol
+ Expand
7

CIRCLE-seq analysis of off-target effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
CIRCLE-seq libraries for each gRNA and a control (Cas9 enzyme only) were prepared following the described protocol (Tsai et al., 2017 (link); Lazzarotto et al., 2018 (link)). Illumina sequencing (Novogene, Sacramento, CA, United States) of the libraries generated ∼5 million reads per sample that were mapped to the zebrafish reference genome (GRCz11/danRer11) to define predicted off-target sites relative to the control sample following the established CIRCLE-Seq bioinformatic pipeline (data has been deposited to the European Nucleotide Archive Accession PRJEB40101). Once potential off-target sites were defined, we PCR amplified a ∼500-bp region of G0 mosaic mutants of the top sites inside genes predicted by CIRCLE-seq (13 for syngap1b and 6 for slc7a5) (primers listed in Supplementary Table S1) and ran a polyacrylamide gel electrophoresis to identify the presence of indels at these sites by the formation of heteroduplexes (Zhu et al., 2014 ). Additionally, if heteroduplexes were detected, PCR reactions were cleaned-up using Ampure XP magnetic beads (Beckman Coulter), and Sanger sequenced (Genewiz, San Diego, CA, United States). We did not observe off-target indels in these sites when compared to WT siblings.
+ Open protocol
+ Expand
8

Confirming Plasmid Integration by PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Short read genomic sequences for each sample were aligned to the donor plasmid pCR 2.1. PCR was used to analyze the orientation of the pCR 2.1 plasmid and confirm the duplication of the HDR template. Primers were developed using Primer3 (ref. 45 (link)) (Supplementary Table 4) to amplify the region flanking the polled locus. The topoIF primer was designed targeting the region upstream of the 5′ end of the polled locus and was paired with the M13R primer for PCR. The topoIR primer was designed targeting the region downstream of the 3′ end of the polled locus and was paired with the M13F primer for PCR (Fig. 5). PCR was performed on a SimpliAmp Thermal Cycler (Applied Biosystems) with 12.5 μl GoTaq Green Master Mix (Promega Biosciences LLC), 9.5 μl of water, 1 μl of each primer at 10 mM and 1 μl of DNA for 5 min at 95 °C, 35 cycles of 30 s at 95 °C, 30 s at 54 °C for topoIF/M13R or 57 °C for M13F/topoIR (Supplementary Table 3) and 2.5 min at 72 °C, followed by 10 min at 72 °C. Products were visualized on a 1% agarose gel using a ChemiDoc-ItTS2 Imager (UVP, LLC), purified using the QIAquick PCR Purification Kit (Qiagen, Inc.) and Sanger sequenced (GeneWiz).
+ Open protocol
+ Expand
9

Validating Extreme Allele-Specific Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
At least one biased SNP per extreme ASE event was analysed using Sanger sequencing. PCR products derived from RNA were prepared from 200 ng total RNA by incubation with Superscript III Reverse Transcriptase (Thermo Fisher) and then cDNA was PCR-amplified with Phusion polymerase (New England Biolabs) using gene-specific primers (Supplementary Data 6) flanking the SNPs of interest. PCR products were gel-purified using the QIAquick Gel Extraction Kit (QIAgen) and Sanger sequenced (GENEWIZ, Boston). The relative peak heights of the ALT and REF alleles were measured. Extreme ASE events were confirmed when the relative peak height was >5.
+ Open protocol
+ Expand
10

Targeted Allele Amplification and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR was used to amplify the tagged allele in two tiled reactions spanning the left and right HAs, the GFP and linker sequence, and portions of the distal genomic region 5′ of the left HA and 3′ of the right HA (Figure 2) using gene-specific primers (Supplemental Table S2). Both tiled junctional PCR products were Sanger sequenced (Genewiz) bidirectionally with PCR primers when their size was validated by gel electrophoresis and/or fragment analysis (Fragment Analyzer; Advanced Analytics Technologies). In final clones, a single, nontiled junctional PCR using the gene-specific external 5′ and 3′ junctional primers (Supplemental Table S2) was used to amplify both the edited and wild-type allele in a single reaction. All PCRs described in this section were prepared using PrimeStar (Takara) 2× GC buffer, 200 µM DNTPs, 1 unit PrimeStar HS polymerase, 800 nM primers, and 10 ng gDNA in a final volume of 25 µl. Cycling conditions were as follows (98°C for 10 s, 70°C for 5 s, 72°C for 60 s) × 6 cycles at −2°C/cycle annealing temperature (98°C for 10 s, 54°C for 5 s, 72°C for 60 s) × 32 cycles, 12°C hold.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!